JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias

A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial

JG Andrade, J Champagne, M Dubuc, MW Deyell… - Circulation, 2019 - Am Heart Assoc
Background: Advanced generation ablation technologies have been developed to achieve
more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial …

[HTML][HTML] Cryoballoon Best Practices II: Practical guide to procedural monitoring and dosing during atrial fibrillation ablation from the perspective of experienced users

W Su, A Aryana, R Passman, G Singh, R Hokanson… - Heart rhythm, 2018 - Elsevier
Since the evaluation of the cryoballoon in the Sustained Treatment Of Paroxysmal Atrial
Fibrillation trial, more than 350,000 patients with atrial fibrillation have been treated. Several …

Cryoballoon versus laserballoon: insights from the first prospective randomized balloon trial in catheter ablation of atrial fibrillation

JKR Chun, S Bordignon, J Last, L Mayer… - Circulation …, 2021 - Am Heart Assoc
Background: Pulmonary vein isolation (PVI) represents the cornerstone in atrial fibrillation
ablation. Cryoballoon and laserballoon catheters have emerged as promising devices but …

Individualized cryoballoon energy pulmonary vein isolation guided by real-time pulmonary vein recordings, the randomized ICE-T trial

KRJ Chun, M Stich, A Fuernkranz, S Bordignon… - Heart rhythm, 2017 - Elsevier
Background The ideal energy dosing remains unclear in second-generation cryoballoon
(CB) pulmonary vein isolation (PVI). We aimed to investigate the effect of an individualized …

[HTML][HTML] Cryoablation for atrial fibrillation

JG Andrade - Heart Rhythm O2, 2020 - Elsevier
Cryoballoon ablation for the treatment of atrial fibrillation has established itself as an
effective and efficient modality for achieving pulmonary vein isolation. Over the past 13 years …

Optimizing cryoballoon pulmonary vein isolation: lessons from> 1000 procedures—the Frankfurt approach

S Bordignon, S Chen, F Bologna, S Thohoku… - EP …, 2021 - academic.oup.com
Aims Cryoballoon (CB) pulmonary vein isolation (PVI) is an accepted ablation strategy for
rhythm control in atrial fibrillation (AF). We describe efficacy and safety in a high volume …

Pulmonary vein isolation using a second‐generation cryoballoon in patients with paroxysmal atrial fibrillation: one‐year outcome using a single big‐balloon 3‐minute …

S Miyazaki, H Hachiya, H Nakamura… - Journal of …, 2016 - Wiley Online Library
Cryoballoon Ablation of PAF Background The second‐generation cryoballoon (CB) has
been recently introduced into clinical use for pulmonary vein isolation (PVI). Data on the …

Use of a novel integrated dilator-needle system in cryoballoon procedures: a zero-exchange approach

SC Yap, RE Bhagwandien, T Szili-Torok - Journal of Interventional …, 2022 - Springer
Background Recently, a novel integrated dilator-needle system (AcQCross Qx, Acutus
Medical) was introduced to reduce the number of exchanges for a transseptal access. This …

[HTML][HTML] Time-to-isolation guided titration of freeze duration in 3rd generation short-tip cryoballoon pulmonary vein isolation–Comparable clinical outcome and shorter …

A Pott, C Kraft, T Stephan, K Petscher… - International journal of …, 2018 - Elsevier
Background The optimal freeze duration in cryoballoon pulmonary vein isolation (PVI) is
unknown. The 3rd generation cryoballoon facilitates observation of the time-to-isolation (TTI) …